The FDA has cleared Idaho Technology's nucleic acid amplification test to diagnose the early stages of Q fever infections in overseas military personnel. Q fever is an emerging infectious disease among U.S. soldiers serving in Iraq and worldwide and can cause acute or chronic illness in humans, who usually acquire infections after contact with infected animals or exposure to contaminated environments. If diagnosed early, most people with Q fever fully recover after treatment with appropriate antibiotics. Failure to treat an infection can, however, result in serious chronic illness. FDA's release